1. Home
  2. YMAT vs XBIO Comparison

YMAT vs XBIO Comparison

Compare YMAT & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo J-Star Holding Co. Ltd. Ordinary Shares

YMAT

J-Star Holding Co. Ltd. Ordinary Shares

N/A

Current Price

$1.01

Market Cap

4.5M

ML Signal

N/A

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

N/A

Current Price

$1.52

Market Cap

4.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YMAT
XBIO
Founded
1970
N/A
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.7M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
YMAT
XBIO
Price
$1.01
$1.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.7M
20.5K
Earning Date
10-23-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.52
EPS
★ N/A
N/A
Revenue
N/A
★ $2,976,411.00
Revenue This Year
N/A
$2.37
Revenue Next Year
N/A
N/A
P/E Ratio
$10.92
★ N/A
Revenue Growth
N/A
★ 19.04
52 Week Low
$0.24
$1.43
52 Week High
$4.49
$4.94

Technical Indicators

Market Signals
Indicator
YMAT
XBIO
Relative Strength Index (RSI) 42.57 33.45
Support Level $0.32 N/A
Resistance Level $2.20 $3.41
Average True Range (ATR) 0.26 0.17
MACD -0.04 -0.01
Stochastic Oscillator 26.53 12.12

Price Performance

Historical Comparison
YMAT
XBIO

About YMAT J-Star Holding Co. Ltd. Ordinary Shares

J-Star Holding Co Ltd is engaged in the research, development, and manufacturing of carbon fiber for a wide variety-of-products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products. The company has five segments: Bicycle frame, Racket, Crank, Service provision, and Others. The majority of its revenue is generated from the Bicycle frame segment. Geographically, the company operates in Taiwan, China, and other regions.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

Share on Social Networks: